Vaccination should be deferred by three months after recovery in individuals having lab test proven SARS-2 COVID-19 illness, the Health Ministry said in a statement issued on Wednesday.
SARS-2 COVID-19 patients who have been given anti-SARS-2 monoclonal antibodies or convalescent plasma should also defer vaccination by three months from the date of discharge from the hospital. This, while recommending COVID-19 vaccination for all lactating women.
The Ministry said it had accepted the recommendations of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC). “These recommendations have been based on the evolving situation of the COVID-19 pandemic and emerging global scientific evidence and experience,” it stated.
It recommended that individuals who have received at least the first dose of the vaccine and got the infection before the completion of the dosing schedule should also defer by three months the second dose after clinical recovery from COVID-19.
“Persons with any other serious general illness requiring hospitalization or ICU care should also wait for 4-8 weeks before getting the COVID-19 vaccine,’’ it noted. Also an individual could donate blood after 14 days of either receipt of COVID-19 vaccine or testing RT-PCR negative, if suffering from COVID-19.
Vaccination of pregnant women
There was no requirement for screening of the vaccine recipients by Rapid Antigen Test (RAT) prior to vaccination. The matter of vaccination of pregnant women was under discussion and further deliberation by the National Technical Advisory Group on Immunization (NTAGI).
“The Health Ministry has written to States and UTs to direct the concerned officials to take note of these recommendations and undertake necessary action for their effective implementation. States have also been advised to undertake training of the vaccination staff at all levels,’’ said the release.